Our results show that although age and stage (grouped as early vs. late) do not affect expression (Fig. 3a, b); metastatic OvCa patients have significantly higher expression of CIP2A when compared to malignant OvCa samples (p = 0.0366) and benign ovarian tumours (p = 0.0326; Fig. 3c). Here, CIP2A is linked to ovarian benign neoplasm.